Status

Current conditions ICD-9-CM:
2003
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
2010
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
2012
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
375.15 TEAR FILM INSUFFICIENCY,UNSPECIFIED
367.89 OTHER DISORDERS OF REFRACTION AND ACCOMMODATION
377.61 ASSOCIATED WITH NEOPLASMS
729.1 MYALGIA AND MYOSITIS, UNSPECIFIED
719.39 PALINDROMIC RHEUMATISM,MULTIPLE SITES
680.0 CARBUNCLE AND FURUNCLE, FACE
378.41 ESOPHORIA
311 DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED
523.8 OTHER PERIODONTAL DISEASES(PERIODONTAL POCKET,GINGIVAL POLYP)
681.02 ONYCHIA AND PARONYCHIA OF FINGER
2013
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
704.8 OTHER DISEASES OF HAIR AND HAIR FOLLICLES
706.1 OTHER ACNE
444.22 ARTERIAL EMBOLISM AND THROMBOSIS OF LOWER EXTREMITY
375.15 TEAR FILM INSUFFICIENCY,UNSPECIFIED
367.89 OTHER DISORDERS OF REFRACTION AND ACCOMMODATION
377.61 ASSOCIATED WITH NEOPLASMS
378.41 ESOPHORIA
728.85 (728.850) SPASM OF MUSCLE
353.4 LUMBOSACRAL ROOT LESIONS,NOT ELSEWHERE CLASSIFIED
780.52 (780.520) OTHER INSOMNIA
788.43 NOCTURIA
2014
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
374.05 TRICHIASIS WITHOUT ENTROPION
372.72 CONJUNCTIVAL HEMORRHAGE
375.15 TEAR FILM INSUFFICIENCY,UNSPECIFIED
367.89 OTHER DISORDERS OF REFRACTION AND ACCOMMODATION
377.61 ASSOCIATED WITH NEOPLASMS
378.41 ESOPHORIA
2015
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
705.83 HIDRADENITIS
698.8 OTHER PRURITIC CONDITIONS
686.9 UNSPECIFIED LOCAL INFECTIONS OF SKIN AND SUBCUTANEOUS TISSUE
686.09 OTHER PYODERMA
272.0 PURE HYPERCHOLESTEROLAEMIA (FAMILIAL HYPERCHOLESTESTEROLEMIA)
729.1 MYALGIA AND MYOSITIS, UNSPECIFIED
719.39 PALINDROMIC RHEUMATISM,MULTIPLE SITES
377.61 ASSOCIATED WITH NEOPLASMS
311 DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED
307.48 REPETITIVE INTRUSIONS OF SLEEP
705.81 DYSHIDROSIS
372.72 CONJUNCTIVAL HEMORRHAGE
680.2 CARBUNCLE AND FURUNCLE, TRUNK
523.3 ACUTE PERIODONTITIS(ACUTE PERICORONITIS)
Current conditions ICD-10-CM:
2016

E780 Pure hypercholesterolemia
G40.909 Epilepsy, unspecified, not intractable, without status epilepticus
L301 Dyshidrosis [pompholyx]
F32.9 Major depressive disorder, single episode, unspecified
D33.2 Benign neoplasm of brain, unspecified
H04.123 Dry eye syndrome of bilateral lacrimal glands
H47.529 Disorders of visual pathways in (due to) neoplasm, unspecified side
H02.052 Trichiasis without entropian right lower eyelid
H11.31 Conjunctival hemorrhage, right eye
H52.6 Other disorders of refraction
H50.51 Esophoria
H02.055 Trichiasis without entropian left lower eyelid
H47.099 Other disorders of optic nerve, not elsewhere classified, unspecified eye
F51.8 Other sleep disorders not due to a substance or known physiological condition
G40.901 Epilepsy, unspecified, not intractable, with status epilepticus
L0881 Pyoderma vegetans
B009 Herpesviral infection, unspecified
J069 Acute upper respiratory infection, unspecified
M79.1 Myalgia
M12.39 Palindromic rheumatism, multiple sites

Current treatment centers:
GP/ The department of Neurosurgical emergency & Critical Care of Chang Gung Memorial Hospital Linkou Branch/ TCM oncology of China Medical University Hospital Cancer Center/ and Taichung Hospital, Ministry of Health and Welfare

Contents of reference sources:
MIMS- Search drug information/ interaction/ images & medical diagnosis.
Complementary and Alternative Healing University- Dictionary of Chinese Herbs. http://alternativehealing.org
Database 醫砭‧沈藥子 http://yibian.hopto.org
Traditional Chinese Medicine (TCM) Wiki http://www.tcmwiki.com/

Wednesday, November 5, 2014

mu xiang 木香

mu xiang 木香
Qing mu xiang (青木香)a wrong substitute, belongs to Aristolochia family, which is toxic to the kidneys.
Pharmaceutical name 英文藥名﹕Radix Aucklandiae
Botanical name 學名﹕Aucklandia lappa Deene/ Saussurea lappa Clarke/ Inula racemosa, Hook fil (土木香,藏木香)/ Aucklandia costus, Falk
Other Names 別 名﹕
guang mu xiang (orginally those that imported from India and came through Guangdong province), yun mu xiang (those grown in Yunnan province)
廣木香(原為印度產木香﹐經廣東入口)﹐雲木香(於雲南種植的木香)
Common Name 英文名﹕costus root.
Distribution 產地﹕mainly in Yunnan, also in Sichuan and Tibet/ 主產於云南。四川﹐ 西藏也有生產。
Properties (characteristics) 性味﹕acrid, bitter, warm/ 辛﹐苦﹐溫。
Channels (meridians) entered 歸經﹕gallbladder, large intestine, spleen, stomach/ 膽﹐大腸﹐脾﹐胃。
Medical functions 藥理﹕
anti fungus
improves movements of digestive tract, relieves flatulence and pain.
anti HBV antigen[1]
抗真菌
促進胃腸蠕動,緩解胃腸氣脹疼痛
抗乙型肝炎病毒,
Actions & Indications 主治﹕
flatulence and pain in the abdomen, diarrhea, vomiting caused by weak digestion. For bronchitis, digestive tract infection: yeast infection, dysentery, and lack of appetite.
氣滯胸腹脹痛,霍亂吐瀉,痢疾 ,裏急後重,慢性胃腸炎 (細菌或真菌感染),支氣管炎﹐食慾不振。
Chemical ingredients 化學成份--
Evaporating oil 揮發油:
Aplotaxene/ 雲木香烯 (單紫杉烯)
(+)-β-costol/ (+)-β-木 香醇
Dehydrocostus lactone/ 脫氫木香內酯
Dihydrodehydrocostus lactone/ 二氫脫 氫木香內酯
α- ionone/ α- 紫 羅蘭酮
β-selnene/ β-芹子烯
saussure alactone/ 風毛菊內酯
Costic acid/ 木香酸
Castunolide/ 木香烯內酯
β-costene/ β-木香烯 (α- 木 香烴)
α- costene/ α- 木 香烯 (α- 木 香烴)
β-elemene/ 欖香烯
β-selinene/ 芹子烯
Dihydrocostunolide/ 二氫木香內酯
Costus lactone/ 木香內酯
Friedelin/ 無羈帖
terpenoids type essential oil/  烯帖類精油
Organic ingredients 有機成份:
Palmitic acid/ 棕櫚酸
Linderic acid/ 天台烏藥酸
Also contains 另含:
calcium oxalate/ 草酸鈣
Dosage 用 量﹕3 ~ 10 g.
Samples of formulae 處方舉例﹕
xiang sha liu jun zi tang 香砂六君子湯
gui pi tang  歸脾湯
Toxicity & Cautions 毒素與禁忌﹕
Beware of using the wrong substitute,  qing mu xiang (root of ma dou ling) (Aristolochia delibis Sieb.) is toxic for the kidneys.
Do not use mu xiang in cases of yinxu (yin deficient) condition.
Allergic reaction: mild abdominal pain, itchiness, tightness in chest
area, and diarrhea.
青木香有毒﹐為 馬兜鈴之根﹐對腎 臟有大毒。不可用。
陰虛, 津液不足 者 慎服木香。 不良反應包括:輕微腹痛,發痒,胸悶,腹瀉。
Note: [1] Antiviral Res. 1995 May;27(1-2):99-109.
(by Joe Hing kwok Chu)

No comments:

Post a Comment